Therefore, we proposed that suppressing the aberrant activated ERK and FOXM1 should exert similar effects of using GRB7 inhibitor in inhibiting the above tumorigenic properties of ovarian cancer cells. The gene discussed is FOXM1; the disease is ovarian carcinoma.